Progressive multifocal leukoencephalopathy in patients receiving rituximab and cyclophosphamide after haplo-identical T-cell replete transplantation and review of the literature. [electronic resource]
Producer: 20190603Description: 127-132 p. digitalISSN:- 2452-3186
- Cyclophosphamide -- administration & dosage
- Female
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Humans
- Immunocompromised Host
- Immunosuppressive Agents -- administration & dosage
- JC Virus -- physiology
- Leukemia, Myeloid, Acute -- immunology
- Leukoencephalopathy, Progressive Multifocal -- diagnosis
- Middle Aged
- Rituximab -- administration & dosage
- Transplantation Conditioning -- adverse effects
- Transplantation, Haploidentical -- adverse effects
- Virus Activation -- drug effects
No physical items for this record
Publication Type: Case Reports; Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.